Sandesh Mahatme
2016
In 2016, Sandesh Mahatme earned a total compensation of $2.8M as Executive Vice President, Chief Financial Officer and Chief Business Officer at Sarepta Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,441 |
|---|---|
| Option Awards | $894,458 |
| Salary | $459,252 |
| Stock Awards | $1,238,311 |
| Other | $24,438 |
| Total | $2,836,900 |
Mahatme received $1.2M in stock awards, accounting for 44% of the total pay in 2016.
Mahatme also received $220.4K in non-equity incentive plan, $894.5K in option awards, $459.3K in salary and $24.4K in other compensation.
Rankings
In 2016, Sandesh Mahatme's compensation ranked 3,417th out of 14,075 executives tracked by ExecPay. In other words, Mahatme earned more than 75.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,417 out of 14,075 | 76th |
Division Manufacturing | 1,191 out of 5,488 | 78th |
Major group Chemicals And Allied Products | 360 out of 1,900 | 81st |
Industry group Drugs | 261 out of 1,543 | 83rd |
Industry Pharmaceutical Preparations | 205 out of 1,173 | 83rd |
Source: SEC filing on April 27, 2017.
Mahatme's colleagues
We found four more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2016.
2016
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2016
David Howton
Sarepta Therapeutics
General Counsel
2016
Shamim Ruff
Sarepta Therapeutics
Senior Vice President, Regulatory Affairs and Quality
2016
Alexander Cumbo
Sarepta Therapeutics